Anviro Therapeutics

About:

Anviro is a broad-spectrum antiviral company that develops treatments for some of the world’s most problematic infectious diseases.

Website: http://Anvirotherapeutics.com

Description:

Anviro Therapeutics is a broad-spectrum antiviral company that develops treatments for some of the world’s most problematic infectious diseases, including pox viruses and herpes viruses. Its lead program is based on technology discovered by researchers at Brigham Young University (BYU). This compound, designated KPB-100, was found to have powerful antiviral properties and efficacy across a wide range of viruses in herpes and pox virus families. In April of 2015, Anviro licensed this technology from BYU and are in the process of medicinal optimization and animal model validation.

Total Funding Amount:

$650000

Headquarters Location:

Orem, Utah, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)AnviroTherapeutics.com

Founders:

Kyle Lane, Matthew Cryer

Number of Employees:

1-10

Last Funding Date:

2016-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai